James Tumlin
NephroNet, Inc. · Georgia Nephrology Research Institute
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James Tumlin as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:24 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT07225387 · Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy TrialNephroNet, Inc. · recruiting · Lupus Nephritis · principal investigator
- Ph2NCT05709444 · A Phase IIb, Multicenter, Open-Label, Prospective Study of Bremelanotide in Diabetic Kidney DiseasePalatin Technologies, Inc · completed · Kidney Disease · principal investigator
- Ph4NCT05546047 · A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy PatientsNephroNet, Inc. · unknown · Fibrillary Glomerulonephritis · principal investigator
- Ph4NCT05535920 · A Prospective, Randomized, Open-Label, Cross-Over Study of Lokelma to Control Interdialytic HyperkalemiaNephroNet, Inc. · completed · Hyperkalemia · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:24 UTC. The ranking covers the 200 most relevant of 37 PubMed records, and a shared surname and initials can bring in a namesake. All 37 on PubMed
- Angiotensin II for the Treatment of Vasodilatory Shock.N Engl J Med · 2017720 citationsRCR 31.9
- 273 citationsRCR 8.5
- 267 citationsRCR 30.3
- A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.J Am Soc Nephrol · 2017243 citationsRCR 9.8
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial.Nephrol Dial Transplant · 2018239 citationsRCR 9.1
- 216 citationsRCR 10.9
- Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.N Engl J Med · 2025216 citationsRCR 63.9
- Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.N Engl J Med · 2021205 citationsRCR 12.7
- Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.Am J Respir Crit Care Med · 2020197 citationsRCR 11.1
- Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.J Am Soc Nephrol · 2015183 citationsRCR 7.5